EMERYVILLE, Calif. & POMPANO BEACH, Fla.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) and BioStem Technologies, Inc. (OTC: BSEM) announce an agreement under which NovaBay has been granted the right to commercialize BioStem Techn…
Author: Business Wire
Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Bausch + Lomb Escrow Corp. (“Escrow Issuer”), a wholly owned …
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence
GENEVA–(BUSINESS WIRE)–Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence
Visus Therapeutics to Present at the Baird 2023 Global Healthcare Conference
SEATTLE & IRVINE, Calif.–(BUSINESS WIRE)–Visus Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapies for indications in the front and back of the eye, today announced that Ben Bergo, c…
STAAR Surgical to Host “Vision 2026” Investor Day on September 14, 2023
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will host an in-person Investor Day on Thursday, September 14, 2023, …
Warby Parker Announces Participation in the Goldman Sachs 30th Annual Global Retailing Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Goldman Sachs 30th Annual Global Retailing Conference …
Kubota Vision Announces Collaborative Research Agreement with China Medical University Hsinchu Hospital
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the execution of a…
New Multicenter Study Reveals Neurological Pupil index™ (NPi) as Predictor of Outcome and Mortality in Brain Injury Patients
IRVINE, Calif.–(BUSINESS WIRE)–A new prospective, multicenter study, recently published in The Lancet Neurology has revealed the significant prognostic value of the Neurological Pupil index™ (NPi®), measured using the NeurOptics NPi Pupillometer, in …
Viridian Therapeutics Announces Presentations at Multiple Medical Meetings in September
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that multiple abstracts feat…
Vivani Medical to Present at the Boulder Peptide Symposium
ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, preclinical-stage biopharmaceutical company that develops novel, long-term drug implants, announced today that it will present at the upco…
flō Announces its Collaboration with the Weizmann Institute of Science regarding Advanced Materials for Optical Use
REHOVOT, Israel–(BUSINESS WIRE)–flō has signed an exclusive license agreement with Yeda Research and Development Co., Ltd. regarding the use of Weizmann Advanced Materials used for optical coatings to be applied via flō’s proprietary Additive Manufac…
Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it has disclosed certain historical and pro forma financial i…
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
GENEVA–(BUSINESS WIRE)–Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation
iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna
FREMONT, Calif.–(BUSINESS WIRE)–Nova Eye Medical Limited, a medical technology company committed to advanced ophthalmic treatment technologies and devices, is pleased to announce that the Company’s proprietary canaloplasty technology platform (iTrack…
Ora, Inc. erscheint in NHS 75: 75-Jahrfeier des National Health Service
BOSTON–(BUSINESS WIRE)–Ora, Inc., die weltweit führende Clinical Research Organisation (CRO) für die Entwicklung von Medikamenten und Geräten für die Augenheilkunde, gab heute ihre Teilnahme an NHS 75 bekannt: ein Buch anlässlich des 75-jährigen Best…
Riassunto: Ora, Inc. inclusa nel NHS 75: Celebrating 75 Years of the National Health Service
BOSTON–(BUSINESS WIRE)–Ora, Inc., l’azienda di Clinical Research (CRO – Clinical Research Organisation) leader al mondo nel settore della oftalmologia farmaceutica e lo sviluppo di dispositivi, ha annunciato oggi di essere stata inclusa nel libro “NH…
Ora Inc. présentée dans le livre « NHS 75: Celebrating 75 Years of the National Health Service »
BOSTON–(BUSINESS WIRE)–Ora Inc., première organisation de recherche clinique (CRO, pour Contract Research Organisation) au monde pour le développement de produits pharmaceutiques et de dispositifs ophtalmologiques, a annoncé ce jour qu’elle figure da…
Ora, Inc. in NHS 75: 75 jaar Nationale Gezondheidszorg
BOSTON–(BUSINESS WIRE)–Ora, Inc., ‘s werelds toonaangevende CRO (Clinical Research Organisation) voor de ontwikkeling van farmaceutische producten en hulpmiddelen voor oogheelkunde, kondigde vandaag haar opname aan in het boek NHS 75: Celebrating 75 …
Ora, Inc. aparece en NHS 75: Celebración de los 75 años del servicio nacional de salud
BOSTON–(BUSINESS WIRE)–Ora, Inc., principal organización mundial de investigación por contrato (CRO) para el desarrollo de productos farmacéuticos y dispositivos oftalmológicos, ha anunciado hoy su inclusión en el libro NHS 75: Celebración de los 75 …
Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced 13 podium and poster presentations during the European Society of …